Strontium-89

Jun 12, 2020

QBioMed to Support and Exhibit at Living Beyond Breast Cancer 2020 Virtual Conference on June 13-14, 2020

Feb 13, 2020

Drug Makers Focusing on Pain Management Alternatives to Opioid Drugs

Nov 20, 2019

Q BioMed Announces FDA Approval

Oct 02, 2019

Q BioMed Announces Legal Settlement and Acquisition of FDA Approved Non-Opioid Metastatic Cancer Pain Drug

Mar 16, 2018

Significant Progress in Non-opioid Therapy Picks up Steam as Market Projected to Reach $22 Billion by 2022

Mar 16, 2018

Q Biomed Inc. Announces FDA Filing for Approval of a New Manufacturing Facility for Non-Opioid Strontium Chloride SR89 Injection USP for Relief of Cancer Bone Pain

Dec 21, 2017

Q BioMed Provides Year End Update

Oct 05, 2017

Q BioMed Announces Launch of PainFreeCancer.com Website in Support of Non-Opioid Cancer Pain Drug

Jun 26, 2017

Q BioMed Inc. Adds Nuclear Medicine Industry Veteran to Commercialization Team

Jun 09, 2017

Q BioMed Announces Attendance at Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting

Jun 07, 2017

Q BioMed Inc Announces Commercialization of Non-Narcotic Metastatic Cancer Pain Drug